Orbimed Advisors LLC Edwards Lifesciences Corp Transaction History

Orbimed Advisors LLC

$4.24 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $9.36 Million - $10.8 Million	-115,000 Reduced 18.25%	515,000 $48.6 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $17.1 Million - $19.5 Million	-230,500 Reduced 26.79%	630,000 $52.1 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $7.23 Million - $9.25 Million	-105,800 Reduced 10.95%	860,500 $64.2 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $3.71 Million - $4.83 Million	-45,000 Reduced 4.45%	966,300 $79.8 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $3.46 Million - $5.13 Million	-40,000 Reduced 3.8%	1,011,300 $96.2 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $2.54 Million - $3.2 Million	-24,900 Reduced 2.31%	1,051,300 $124 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $5.34 Million - $6.56 Million	-50,200 Reduced 4.46%	1,076,200 $139 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $7.92 Million - $9.12 Million	100,600 Added 9.81%	1,126,400 $94.2 Million
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $22.9 Million - $29.1 Million	319,300 Added 45.19%	1,025,800 $93.6 Million
Q3 2020 Nov 16, 2020	BUY	$67.19 - $87.44 $11.8 Million - $15.4 Million	176,100 Added 33.2%	706,500 $56.4 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $20.3 Million - $27.2 Million	353,600 Added 200.0%	530,400 $36.7 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $13.5 Million - $20.9 Million	-258,100 Reduced 59.35%	176,800 $33.3 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $5.23 Million - $5.98 Million	-72,900 Reduced 14.36%	434,900 $101 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $12.8 Million - $15.6 Million	-207,200 Reduced 28.98%	507,800 $112 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $11.9 Million - $16 Million	249,400 Added 53.57%	715,000 $137 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $24.4 Million - $29.9 Million	-525,000 Reduced 53.0%	465,600 $71.3 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $5.47 Million - $6.95 Million	119,700 Added 13.74%	990,600 $172 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $6.52 Million - $7.88 Million	-153,700 Reduced 15.0%	870,900 $127 Million
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $3.7 Million - $4.72 Million	-99,500 Reduced 8.85%	1,024,600 $143 Million
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $9.01 Million - $10.5 Million	-266,600 Reduced 19.17%	1,124,100 $127 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $50.5 Million - $54 Million	1,390,700	1,390,700 $152 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account